Nawrot, I.;Czerwinska, Katarzyna;Machura, B.;Kruszynski, R. published 《Synthesis, structural diversity and luminescent properties of cadmium(II) coordination assemblies with 2-(2-aminophenyl)-1H-benzimidazole and pseudohalide ions》 in 2017. The article was appeared in 《Journal of Luminescence》. They have made some progress in their research.Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline The article mentions the following:
A systematic investigation of Cd(II)-(apbim)-X systems (apbim=2-(2-aminophenyl)-1H-benzimidazole and X=N–3,SCN– and N(NC)–2) was conducted, and the following cadmium(II) coordination compounds [Cd(N3)2(apbim)]n•nMeOH (1), [Cd(SCN)2(apbim)]n•nMeOH (2), [Cd(dca)(apbim)2]n•n(NO3) (3), [Cd(SCN)2(apbim)2] (4) and [Cd(dca)2(apbim)2]•H2O (5) were successfully synthesized and characterized by single-crystal diffraction, X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) anal. and IR spectroscopy. The luminescent properties of 2-(2-aminophenyl)-1H-benzimidazole and cadmium(II) coordination compounds were studied in solution (4 and 5) and solid state (1-5). The studies revealed that the solid state architecture and solid state photoluminescent properties of the Cd(II)-apbim-X systems (X=N3, NCS– and dca–) are strongly influenced by intermol. interactions. To complete the study, the researchers used 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .
2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.
Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem